D'Lauro Christopher, Register-Mihalik Johna K, Meier Timothy B, Kerr Zachary Yukio, Knight Kristen, Broglio Steven P, Leeds Daniel, Lynall Robert C, Kroshus Emily, McCrea Michael A, McAllister Thomas W, Schmidt Julianne D, Master Christina, McGinty Gerald, Jackson Jonathan C, Cameron Kenneth L, Buckley Thomas, Kaminski Thomas, Mihalik Jason P
Department of Behavioral Sciences and Leadership, United States Air Force Academy, Colorado Springs, Colorado, USA.
Investigation performed at University of Georgia, Athens, Georgia, USA.
Am J Sports Med. 2024 Mar;52(3):801-810. doi: 10.1177/03635465231221782. Epub 2024 Feb 10.
Timely and appropriate medical care after concussion presents a difficult public health problem. Concussion identification and treatment rely heavily on self-report, but more than half of concussions go unreported or are reported after a delay. If incomplete self-report increases exposure to harm, blood biomarkers may objectively indicate this neurobiological dysfunction.
PURPOSE/HYPOTHESIS: The purpose of this study was to compare postconcussion biomarker levels between individuals with different previous concussion diagnosis statuses and care-seeking statuses. It was hypothesized that individuals with undiagnosed concussions and poorer care seeking would show altered biomarker profiles.
Cohort study; Level of evidence, 3.
Blood samples were collected from 287 military academy cadets and collegiate athletes diagnosed with concussion in the Advanced Research Core of the Concussion Assessment, Research and Education Consortium. The authors extracted each participant's self-reported previous concussion diagnosis status (no history, all diagnosed, ≥1 undiagnosed) and whether they had delayed or immediate symptom onset, symptom reporting, and removal from activity after the incident concussion. The authors compared the following blood biomarkers associated with neural injury between previous concussion diagnosis status groups and care-seeking groups: glial fibrillary acidic protein, ubiquitin c-terminal hydrolase-L1 (UCH-L1), neurofilament light chain (NF-L), and tau protein, captured at baseline, 24 to 48 hours, asymptomatic, and 7 days after unrestricted return to activity using tests of parallel profiles.
The undiagnosed previous concussion group (n = 21) had higher levels of NF-L at 24- to 48-hour and asymptomatic time points relative to all diagnosed (n = 72) or no previous concussion (n = 194) groups. For those with delayed removal from activity (n = 127), UCH-L1 was lower at 7 days after return to activity than that for athletes immediately removed from activity (n = 131). No other biomarker differences were observed.
Individuals with previous undiagnosed concussions or delayed removal from activity showed some different biomarker levels after concussion and after clinical recovery, despite a lack of baseline differences. This may indicate that poorer care seeking can create neurobiological differences in the concussed brain.
脑震荡后及时且恰当的医疗护理是一个棘手的公共卫生问题。脑震荡的识别和治疗严重依赖自我报告,但超过半数的脑震荡未被报告或延迟报告。如果不完整的自我报告增加了伤害风险,血液生物标志物可能会客观地显示这种神经生物学功能障碍。
目的/假设:本研究的目的是比较不同既往脑震荡诊断状态和就医状态个体的脑震荡后生物标志物水平。研究假设是,未诊断出脑震荡且就医情况较差的个体将表现出生物标志物谱的改变。
队列研究;证据等级,3级。
从287名在脑震荡评估、研究与教育联盟高级研究核心中被诊断为脑震荡的军校学员和大学生运动员中采集血样。作者提取了每位参与者自我报告的既往脑震荡诊断状态(无病史、所有脑震荡均已诊断、≥1次未诊断),以及他们在此次脑震荡事件后症状发作、症状报告和停止活动是延迟还是立即发生。作者比较了既往脑震荡诊断状态组和就医状态组之间与神经损伤相关的以下血液生物标志物:胶质纤维酸性蛋白、泛素C末端水解酶-L1(UCH-L1)、神经丝轻链(NF-L)和tau蛋白,这些标志物在基线、24至48小时、无症状时以及 unrestricted return to activity(此处可能有误,推测为“ unrestricted return to normal activity”,即无限制恢复正常活动)7天后采集,采用平行轮廓检验。
相对于所有已诊断(n = 72)或无既往脑震荡(n = 194)组,既往未诊断出脑震荡组(n = 21)在24至48小时和无症状时间点的NF-L水平较高。对于那些延迟停止活动的人(n = 127),恢复活动7天后的UCH-L1低于立即停止活动的运动员(n = 131)。未观察到其他生物标志物差异。
既往有未诊断出脑震荡或延迟停止活动的个体,尽管缺乏基线差异,但在脑震荡后及临床恢复后显示出一些不同的生物标志物水平。这可能表明较差的就医情况会在脑震荡后的大脑中产生神经生物学差异。